Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease

INTRODUCTION: Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. METHODS: We performed a post hoc pooled efficacy and safety analysis that included HCV genotype 1–infected patients with compensated liver disease and CKD stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, David E., Tran, Albert, Martin, Paul, Kowdley, Kris V., Bourliere, Marc, Sulkowski, Mark S., Pockros, Paul J., Renjifo, Boris, Wang, Deli, Shuster, Diana L., Cohen, Daniel E., Jacobson, Ira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365509/
https://www.ncbi.nlm.nih.gov/pubmed/30775621
http://dx.doi.org/10.1016/j.ekir.2018.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365509/
https://www.ncbi.nlm.nih.gov/pubmed/30775621
http://dx.doi.org/10.1016/j.ekir.2018.10.005

Ejemplares similares